These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 20821873)

  • 1. The significance of the International Normalized Ratio (INR) for oral anticoagulant therapy.
    van den Besselaar AM
    J Int Fed Clin Chem; 1991 Sep; 3(4):146-53. PubMed ID: 20821873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardization of coagulation tests.
    Opartkiattikul N
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International standardization of laboratory control of oral anticoagulant therapy: a survey of thromboplastin reagents used for prothrombin time testing.
    van den Besselaar AM
    J Heart Valve Dis; 1993 Jan; 2(1):42-52. PubMed ID: 8269109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system.
    Testa S; Morstabilini G; Fattorini A; Galli L; Denti N; D'Angelo A
    Haematologica; 2002 Dec; 87(12):1265-73. PubMed ID: 12495900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precision and accuracy of the international normalized ratio in oral anticoagulant control.
    van den Besselaar AM
    Haemostasis; 1996 Oct; 26 Suppl 4():248-65. PubMed ID: 8979131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability and clinical impact of the normalization of the prothrombin times in oral anticoagulant control.
    Loeliger EA; van den Besselaar AM; Lewis SM
    Thromb Haemost; 1985 Feb; 53(1):148-54. PubMed ID: 3992514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Questions and answers on prothrombin time standardisation in oral anticoagulant control.
    Loeliger EA; Poller L; Samama M; Thomson JM; Van den Besselaar AM; Vermylen J; Verstraete M
    Thromb Haemost; 1985 Aug; 54(2):515-7. PubMed ID: 4082086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral anticoagulant therapy control: evidence that INR expression improves the inter-laboratory comparability of results--the Bologna oral anticoagulant control exercise.
    Palareti G; Coccheri S; Poggi M; Bonetti M; Cervi V; Mazzuca A; Savoia M; Veri L; Fiori F; Gaspari G
    Thromb Haemost; 1987 Oct; 58(3):905-10. PubMed ID: 3433253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral anticoagulant monitoring by laboratory or near-patient testing: what a clinician should be aware of.
    Tripodi A; Breukink-Engbers WG; van den Besselaar AM
    Semin Vasc Med; 2003 Aug; 3(3):243-54. PubMed ID: 15199457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining a metrologically traceable and sustainable calibration hierarchy of international normalized ratio for monitoring of vitamin K antagonist treatment in accordance with International Organization for Standardization (ISO) 17511:2020 standard: communication from the International Federation of Clinical Chemistry and Laboratory Medicine-SSC/ISTH working group on prothrombin time/international normalized ratio standardization.
    van den Besselaar AMHP; Stavelin A; Kitchen S; Bryant M; Tripodi A; Scalambrino E; Clerici M; Herbel P; Jünschke A; Meyer Dos Santos S; Meijer P; Niessen RWLM; Meijers JCM; Thelwell C; Cuker A; Kung C; Cao Z; Zander N; Iwasaki Y; Depasse F; van Rijn C; Baktawar S; Abdoel C; Cobbaert CM
    J Thromb Haemost; 2024 Apr; 22(4):1236-1248. PubMed ID: 38128762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Control of oral anticoagulation. Current concepts].
    Aguilar CA; Hurtado Monroy R; Gaspar Hernández J
    Rev Invest Clin; 1989; 41(4):371-4. PubMed ID: 2698502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of EDTA samples for prothrombin time measurement in patients receiving oral anticoagulants.
    Horsti J
    Haematologica; 2001 Aug; 86(8):851-5. PubMed ID: 11522542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of frozen plasma calibrants for enhanced standardization of the international normalized ratio (INR): a multi-center study.
    Adcock DM; Johnston M
    Thromb Haemost; 2002 Jan; 87(1):74-9. PubMed ID: 11848460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ASHP therapeutic position statement on the use of the International Normalized Ratio system to monitor oral anticoagulant therapy.
    Am J Health Syst Pharm; 1995 Mar; 52(5):529-31. PubMed ID: 7606561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biological monitoring of treatment with antivitamin K. Value of INR and definition of new therapeutic ranges. A study of 73 patients].
    Gouin I; Horellou MH; Conard J; Samama M
    Arch Mal Coeur Vaiss; 1990 Mar; 83(3):357-61. PubMed ID: 2108630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulant therapy monitoring with international normalized ratio at US academic health centers.
    Yim JM; Albers GW; Vlasses PH
    Ann Pharmacother; 1996 Dec; 30(12):1390-5. PubMed ID: 8968449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of INRs determined with a whole blood prothrombin time device and two international reference preparations for thromboplastin.
    van den Besselaar AM
    Thromb Haemost; 2000 Sep; 84(3):410-2. PubMed ID: 11019963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standardization of the prothrombin time in oral anticoagulant control.
    van den Besselaar AM
    Haemostasis; 1985; 15(4):271-7. PubMed ID: 4043828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio?
    Robert A; Chazouillères O
    Hepatology; 1996 Dec; 24(6):1392-4. PubMed ID: 8938167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality assurance program for whole blood prothrombin time-international normalized ratio point-of-care monitors used for patient self-testing to control oral anticoagulation.
    Tripodi A; Bressi C; Carpenedo M; Chantarangkul V; Clerici M; Mannucci PM
    Thromb Res; 2004; 113(1):35-40. PubMed ID: 15081563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.